We prospectively evaluated 46 patients who had intrahisian conduction delay. Twenty-three had a split His potential 23 had a prolonged HV interval with a normal QRS complex. In those with a split His, the interval between the two His potentials averaged 32.7 msec (range 9-90 msec); in nine patients this split His was demonstrated only by atrial pacing. The 20 patients from this group with 1: 1 atrioventricular conduction have been followed for an average of 18.1 months (range 2-48 months). All are alive. Three have had syncope, but Holter monitoring revealed no bradyarrhythmias.
In the 23 patients with a narrow QRS prolonged HV interval, the HV interval averaged 73.7 msec (range 57-180 msec). Twelve of these patients received pacemakers at the time of the His bundle study, six had symptomatic atrioventricular block five had symptomatic sinus pauses. The 11 patients who did not receive pacemakers have been followed for an average of 15.1 months (range 2–44 months). In three with recurrent syncope five with dizziness, monitoring has revealed no bradyarrhythmias. One patient died from a myocardial infarction without arrhythmias.
Further prospective evaluation of patients with intrahisian conduction delay without documented bradyarrhythmias is needed, but with follow-up averaging 17 months up to 4 years, patients with intrahisian conduction delay without documented bradyarrhythmias appear not to require prophylactic permanent pacemakers to decrease morbidity or mortality.